6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid

Catalog No. :
ACBTIX046
CAS No. :
3050984-63-6
Molecular Formula :
C13H19NO6
Molecular Weight :
285.30

IUPAC Name:6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid

6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$188.00Login to see priceIn stockInquiry
250mg95%$375.00Login to see priceIn stockInquiry
500mg95%$562.00Login to see priceIn stockInquiry
1g95%$937.00Login to see priceIn stockInquiry
5g95%$2809.00Login to see priceIn stockInquiry
10g95%$4681.00Login to see priceIn stockInquiry
25g95%$9361.00Login to see priceIn stockInquiry
50g95%$14041.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid
IUPAC Name6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid
Molecular FormulaC13H19NO6
Molecular Weight285.30
SMILESCC(C)(C)OC(=O)N1C2CC1CC(C(=O)O)(C(=O)O)C2
InChI KeyPTOXZFNFSKOGCI-UHFFFAOYSA-N
Synonym6-Azabicyclo[3.1.1]heptane-3,3,6-tricarboxylic acid, 6-(1,1-dimethylethyl) ester;6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3,3-dicarboxylic acid
CAS No.3050984-63-6

Synthetic Route by SureRoute

1. ACBTIX046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBTIX046 route product structure diagram
    ACBTIX0463050984-63-6 In Stock
Inquiry

2. ACBTIX046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBTIX046 route product structure diagram
    ACBTIX0463050984-63-6 In Stock
Inquiry

Comments (0)